Assessing clinical implications and perspectives of the pathophysiological effects of erythrocytes and plasma free hemoglobin in autologous biologics for use in musculoskeletal regenerative medicine therapies
expensive and cumbersome culturing and expansion techniques. Numerous commercial PRP and BMSC systems are available but reports and knowledge of bio-cellular formulations produced by these systems are limited. This

